Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
What are lash serums and how do they work? “Lash serums are topical treatments that are applied to your eyelashes to enhance ...
MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.
Barchart on MSN
What to expect from Amgen's Q4 2025 earnings report
The drug manufacturing giant is expected to announce its fiscal fourth-quarter earnings for 2025 in the near term. Ahead of ...
Check out some of the medications affected by drugmakers raising prices on life-saving medications this year, as well as some ...
About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so ...
Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have never had a heart attack or stroke, according to results from a ...
THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha ® (evolocumab) achieved ...
The clinical benefits and safety of Repatha have been studied for 15 years in 51 clinical trials with over 57,000 patients. 3,4 Repatha is approved in 74 countries, including the U.S., Japan, Canada ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback